Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-230,000
Closed -$1.68M 690
2024
Q1
$1.68M Buy
+230,000
New +$1.97M 0.01% 535
2021
Q3
Sell
-851,291
Closed -$6.45M 877
2021
Q2
$6.45M Sell
851,291
-520,926
-38% -$3.85M 0.04% 358
2021
Q1
$8.53M Hold
1,372,217
0.07% 276
2020
Q4
$8.88M Buy
1,372,217
+734,574
+115% +$4.36M 0.07% 284
2020
Q3
$3.35M Buy
+637,643
New +$3.83M 0.03% 417
2018
Q4
Sell
-300,000
Closed -$1.3M 813
2018
Q3
$1.3M Hold
300,000
0.02% 578
2018
Q2
$1.11M Hold
300,000
0.02% 589
2018
Q1
$1.51M Hold
300,000
0.03% 527
2017
Q4
$1.98M Buy
+300,000
New +$1.78M 0.03% 458

Other funds holding ARDX

Candriam SCA's ARDX Position: Q2 2024 in Review

Candriam SCA sold out of Ardelyx (ARDX) in Q2 2024, closing a stake of 230,000 shares — an estimated $1.68M sold.

Candriam SCA first reported a position in ARDX in Q4 2017 and held it in 9 quarters. The position peaked at $8.88M in Q4 2020. 197 funds tracked by Wall St. Rank hold ARDX as of Q2 2024.

  • Candriam SCA reported no remaining Ardelyx position as of Q2 2024 after selling out during the quarter.
  • Candriam SCA sold 230,000 Ardelyx shares in Q2 2024, an estimated $1.68M.
  • Candriam SCA first reported a position in Ardelyx in Q4 2017 and held it in 9 quarters.
  • Candriam SCA's Ardelyx position peaked at $8.88M in Q4 2020.
  • 197 funds tracked by Wall St. Rank held Ardelyx as of Q2 2024.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.